Pharmaceutical News Headlines for June 26 2012 ( Tuesday )

• Roche (RHHBY) to Cut 1,000 Research Jobs in U.S. More...

• Quintiles, Inc. (QTRN) Offers 100 Jobs to Merck Serono Employees Affected by Cuts More...

• AMAG Pharmaceuticals, Inc. (AMAG) to Reduce Workforce, Divest Manufacturing Facility in Cambridge More...

• Interpublic Pays Up to $78 Million for UK Double Helix More...

• Affymetrix (Santa Clara, California) (AFFX) Completes Acquisition eBioscience, Inc. Holding Company, Inc. More...

• Medivir AB (MVIRb.F) Initiates Collaboration With Swedish University of Agricultural Sciences to Develop New Drugs for Bacterial Infections More...

• IMPAX Laboratories, Inc. (IPXL) Enters Into Development, Supply and Distribution Agreement With TOLMAR Inc. More...

• Cobra Biologics Ltd. and KAHR Medical Extend their Partnership to Develop Both KAHR-101 and KAHR-102 More...

• Helix Biopharma (CC:HBP) Board Approves Selection of Robert Verhagen as CEO; Plans to Voluntarily Delist from NYSE Market More...

• DiaGenic ASA Announces Paul de Potocki as New CEO More...

• Dunsire Joins Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Board as Its First Female Director More...

• ContraFect Corporation Announces Appointment of Sir Richard Sykes to Board of Directors More...

• Leading Clinical and Data Management Talent Will Fuel DaVita Clinical Research's New Denver Facility More...

• Onyx Pharmaceuticals, Inc. (ONXX) Set to Reap Big Gains More...

• Merck & Co., Inc. (MRK) Overstated Mumps Vaccine Effectiveness? More...

• Sartorius Corporation Officially Opens New Filter and Aseptic Bag Production Facility in Puerto Rico More...

• Amarillo Biosciences (AMAR) Announces Plan to Open Asia Operations Center in Taipei, Taiwan More...

• Supernus (SUPN) Shares Soar After Epilepsy Drug Gets FDA Nod More...

• Watson Pharmaceuticals, Inc. (WPI) Files for FDA Approval of Generic Version of Pfizer Inc. (PFE)'s Pristiq More...

• MAP Pharmaceuticals, Inc. (MAPP) to Resubmit Application for Migraine Treatment This Year More...

• Dynavax Technologies Corporation (DVAX) Announces FDA Acceptance of HEPLISAV(TM) BLA More...

• FDA Approves Beckman Coulter, Inc. (BEC)'s New Blood Test to Improve Prostate Cancer Detection More...

• AEterna Zentaris (AEZS): Final Phase 3 Results for AEZS-130 in Adult Growth Hormone Deficiency Presented at ENDO Meeting More...

• Cincinnati Children's Hospital Medical Center Release: Clinical Trial First to Test Heart Drug Regimen for Duchenne Muscular Dystrophy More...

• Data From Phase II Trial of PROLOR Biotech (PBTH)'s Long-acting Human Growth Hormone Presented at Endo 2012 More...

• Provectus Pharmaceuticals Inc.' Top-Line Final Phase 2 Data on PV-10 Presented at 2nd European Post-Chicago Melanoma Meeting 2012 on June 22, 2012 More...

• Key Results from Auris Medical AG's Phase IIb Study of AM-101 in Acute Inner Ear Tinnitus Presented at International Conference More...

• New Hormonal Gel Combination Shows Promise as Reversible Birth Control for Men, Los Angeles Biomedical Research Institute Study More...

• Delaying ADHD Meds Could Hurt Kids' Math Scores, Mount Sinai School of Medicine Study More...

• Treating Vitamin D Deficiency May Improve Depression, Bayhealth Medical Center Study More...

• Overweight Men Can Boost Low Testosterone Levels by Losing Weight, St. Vincent's University Hospital Study More...

• Plastics Chemical Linked to Obesity in Kids, Inje University College of Medicine Study More...

• PTO Issues New Patent to Star Scientific , Inc. Covering Synthesis of Anatabine More...

• Pozen, Inc. (POZN) Receives Patent on PA Products for Treatment of Cardiovascular Disease and Osteoarthritis More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply